Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.007x

Based on the latest financial reports, Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) has a cash flow conversion efficiency ratio of 0.007x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs8.20 Million ≈ $88.66K USD) by net assets (Rs1.19 Billion ≈ $12.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Aarey Drugs & Pharmaceuticals Limited to measure how many days the company can operate on defensive assets alone.

Aarey Drugs & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Aarey Drugs & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Aarey Drugs & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aarey Drugs & Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Culico Metals Inc. V:CLCO	N/A
Mogo Inc TO:MOGO	0.039x
Daegu Dept Sto KO:006370	-0.045x
Radiant Innovation TWO:3373	0.020x
Nara Mold & Die Co. Ltd KQ:051490	0.012x
Cytosorbents Crp NASDAQ:CTSO	-0.530x
Kurniamitra Duta Sentosa Tbk JK:KMDS	0.002x
Atec T& Co. Ltd KQ:224110	-0.026x

Annual Cash Flow Conversion Efficiency for Aarey Drugs & Pharmaceuticals Limited (2009–2025)

The table below shows the annual cash flow conversion efficiency of Aarey Drugs & Pharmaceuticals Limited from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see AAREYDRUGS market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs1.38 Billion ≈ $14.98 Million	Rs8.95 Million ≈ $96.77K	0.006x	+128.66%
2024-03-31	Rs1.33 Billion ≈ $14.36 Million	Rs-29.94 Million ≈ $-323.77K	-0.023x	-106.66%
2023-03-31	Rs1.17 Billion ≈ $12.70 Million	Rs-12.81 Million ≈ $-138.55K	-0.011x	+72.40%
2022-03-31	Rs1.14 Billion ≈ $12.29 Million	Rs-44.93 Million ≈ $-485.90K	-0.040x	-171.37%
2021-03-31	Rs988.60 Million ≈ $10.69 Million	Rs54.77 Million ≈ $592.32K	0.055x	+79.06%
2020-03-31	Rs923.46 Million ≈ $9.99 Million	Rs28.57 Million ≈ $309.00K	0.031x	+288.83%
2019-03-31	Rs865.53 Million ≈ $9.36 Million	Rs6.89 Million ≈ $74.48K	0.008x	+103.14%
2018-03-31	Rs802.45 Million ≈ $8.68 Million	Rs-203.51 Million ≈ $-2.20 Million	-0.254x	-1427.42%
2017-03-31	Rs503.60 Million ≈ $5.45 Million	Rs9.62 Million ≈ $104.05K	0.019x	-87.61%
2016-03-31	Rs366.97 Million ≈ $3.97 Million	Rs56.59 Million ≈ $612.01K	0.154x	+67.84%
2015-03-31	Rs354.09 Million ≈ $3.83 Million	Rs32.53 Million ≈ $351.84K	0.092x	+851.96%
2014-03-31	Rs345.21 Million ≈ $3.73 Million	Rs-4.22 Million ≈ $-45.62K	-0.012x	-112.13%
2013-03-31	Rs334.70 Million ≈ $3.62 Million	Rs33.72 Million ≈ $364.71K	0.101x	+136.83%
2012-03-31	Rs328.12 Million ≈ $3.55 Million	Rs-89.76 Million ≈ $-970.74K	-0.274x	+39.84%
2011-03-31	Rs219.05 Million ≈ $2.37 Million	Rs-99.61 Million ≈ $-1.08 Million	-0.455x	-254.49%
2010-03-31	Rs92.08 Million ≈ $995.81K	Rs-11.81 Million ≈ $-127.73K	-0.128x	-3666.00%
2009-03-31	Rs83.97 Million ≈ $908.15K	Rs302.06K ≈ $3.27K	0.004x	--

About Aarey Drugs & Pharmaceuticals Limited

NSE:AAREYDRUGS India Drug Manufacturers - Specialty & Generic

Market Cap

$25.11 Million

Rs2.32 Billion INR

Market Cap Rank

#24395 Global

#1343 in India

Share Price

Rs81.89

Change (1 day)

+1.54%

52-Week Range

Rs50.75 - Rs99.25

All Time High

Rs99.25